Effective July 1, 2023: A Medicare Payment Limit and ASP has been published for J1954 – 6/16/2023

Effective July 1, 2023:

A Medicare Payment Limit and ASP1 has been published by CMS for:

J1954:Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg

J1954 is a unique HCPCS code for Cipla’s version of LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) and should not be used for billing other leuprolide formulations.

HCPCS

Code

HCPCS Code

Descriptor

NDC

Number

Medicare Payment Limit Effective 7/1/23

ASP

J1954

Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg

69097-0909-50

$425.48

$401.39

We respectfully request the update of all claims and reimbursement systems to include the ASP for J1954: Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg.effective July 1, 2023

Please contact us @ Account.Management@Cipla.com

Reference: 1. Centers for Medicare and Medicaid, Q3 2023 ASP file https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2023-asp-drug-pricing-files

© Copyright 2023 Cipla USA Inc. All rights reserved

June 2023   CUSAI-06162023-01